DDInter1642 DDInter1838
Sargramostim is a human recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) expressed in yeast. It is a glycoprotein that is 127 residues. Substitution of Leu23 leads to a difference from native protein.
Murine IgG2a lambda monoclonal antibody against CD20 antigen (2 heavy chains of 451 residues, 2 lambda chains of 220 residues). It is produced in an antibiotic-free culture of mammalian cells. It can be covalently linked to Iodine 131 (a radioactive isotope of iodine).
Tositumomab {u} may cause a minor interaction that can limit clinical effects when taken with {v} Capsicum
Tositumomab {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Duloxetine
Tositumomab {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Anakinra
Tositumomab {u} may lead to a major life threatening interaction when taken with {v} Measles virus vaccine live attenuated
Tositumomab {u} may lead to a major life threatening interaction when taken with {v} Bivalirudin
Tositumomab {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} and {u} may lead to a major life threatening interaction when taken with {v} Ketorolac
Tositumomab may cause a minor interaction that can limit clinical effects when taken with Capsicum
Tositumomab may cause a moderate interaction that could exacerbate diseases when taken with Duloxetine
Tositumomab may cause a moderate interaction that could exacerbate diseases when taken with Anakinra
Tositumomab may lead to a major life threatening interaction when taken with Measles virus vaccine live attenuated
Tositumomab may lead to a major life threatening interaction when taken with Bivalirudin
Tositumomab may cause a moderate interaction that could exacerbate diseases when taken with Ketorolac and Tositumomab may lead to a major life threatening interaction when taken with Ketorolac